Publication date: December 2026 Source: Cytotherapy, Volume 28, Issue 12 Author(s): Antonio Scatena, Sarah Saietz, Sean Werner, David Stull, Christopher Harrison, Manufacturing Materials Safety & Technology Working Group (formerly the Particulate Working Group) Within the ISCT Process Development & Manufacturing Committee
A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework. // Digital Chinese Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S146532492600890X?dgcid=rss_sd_all
A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework. Digital Chinese Medicine. https://www.sciencedirect.com/science/article/pii/S146532492600890X?dgcid=rss_sd_all
“A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework.” Digital Chinese Medicine.
@article{article5268,
title = {A regulatory gap: addressing visible particle control in cell and gene therapies through a risk-based framework},
journal = {Digital Chinese Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S146532492600890X?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Cytotherapy, Volume 29, Issue 1 Author(s): Matic Bartol, Tina Fink, Tina Tragin, Ema Pleško, Roman Jerala, Hana Esih, Aljaž Kravanja, Brina Štante, Valentina Bianco, Luka Fajs, Mojca Jež